Neurological presentations of a secondary antiphospholipid syndrome
Year: 2017, volume 13 Issue: №1 Pages: 139-143
Heading: Neurology Article type: Case report
Authors: Yesaulenko I.E., Kutashov V.A., Ulyanova O.V.
Organization: Voronezh State Medical University n.a. N.N. Burdenko
Heading: Neurology Article type: Case report
Authors: Yesaulenko I.E., Kutashov V.A., Ulyanova O.V.
Organization: Voronezh State Medical University n.a. N.N. Burdenko
Summary:
The aim of the study is to turn the attention of specialists to antiphospholipid syndrome (APS), which is of interest to physicians of many specialties. The observation of the patient W., 32 years, with secondary APS was analyzed. Poor prognostic factors in CFA are the high frequency of thrombotic complications and thrombocytopenia, and laboratory markers — the presence of lupus anticoagulant. All patients with APS should be under medical supervision, whose main task is to assess the risk of recurrence of venous or arterial thrombosis and its prevention.
Keywords: 32-glycoprotein I, antiphospholipid syndrome , epileptic seizures , lupus anticoagulant , venous thrombosis
Bibliography:
1. Nasonov ELantiphospholipid syndrome. M.: Litterra, 2004; 440 p.
2. Nasonova VI Selected lectures on clinical rheumatology. M.: Meditsina, 2001; 200 p.
3. Reshetnyak ТМ Antiphospholipid syndrome: diagnosis and treatment principles. Consilium medicum 2002; (4): 408-415
4. Reshetnyak ТМ. Antiphospholipid syndrome: current status and challenges for the future. Scientific-Practical Rheumatology 2013; 51 (1): 11-14
5. Bitsadze VO, Khizroeva DH, Makatsaria NA. Antiphospholipid antibodies, their pathogenic and diagnostic significance for obstetric pathology. Obstetrics, Gynecology and Reproduction 2014; (2): 39-60
6. Yesaulenko IE, Kutasov VA, Ulyanova OV. Some aspects of diagnosis, clinical presentation and treatment of antiphospholipid syndrome. Young Scientist 2016; 14 (118): 221-226
7. Kalashnikova LA. Neurology of antiphospholipid syndrome. M.: Medicine, 2003; 256 p.
8. Kondratyeva LV, Reshetnyak ТМ. Prevention of thrombosis in antiphospholipid syndrome. Modern Rheumatology 2009; (3): 18-22
9. Ulyanova OV, Kutasov VA, Khabarova TY. Features of neurological manifestations in patients with antiphospholipid syndrome. Bulletin of KazNMU 2016; (2): 333-339
10. Ulyanova OV, Kutasov VA., Budnevsky AV The Catastrophic antiphospholipid syndrome. Cardiovascular Therapy and Prevention 2016; 1 (15): 167-168.
| Attachment | Size |
|---|---|
| 2017_01-1_139-143.pdf | 243.92 KB |
Русский
English